Dispersyn Gerrit 4
4 · Phio Pharmaceuticals Corp. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Common stock, $0.0001 par value
2021-03-01+68,450→ 84,828 total - Purchase
Common stock, $0.0001 par value
2021-03-03$3.03/sh+2,500$7,575→ 87,328 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments.
- [F2]Includes shares of common stock underlying unvested restricted stock units.